en

PRODUCT DETAIL

CRESEMBA 200 mg prášok na prípravu infúzneho koncentrátu

Code 6526B
MA number EU/1/15/1036/001
Product Form: plc ifc 1x200 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU Orphan
Therapeutic Class: 26 - ANTIMYCOTICA (LOKÁLNE A CELKOVÉ)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J02 ANTIMYCOTICS FOR SYSTEMIC USE
J02A ANTIMYCOTICS FOR SYSTEMIC USE
J02AC Triazole and tetrazole derivatives
J02AC05 Isavuconazole
Shelf life: 48
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 15.10.2015
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 19.08.2020
eu-flag.png sk-flag.png